David Baltimore

California Institute of Technology — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

209h-index171.9kcitations1.1kworks3.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Virus-based gene therapy research(142), Viral Infections and Immunology Research(106), Immune Cell Function and Interaction(101), T-cell and B-cell Immunology(94), Monoclonal and Polyclonal Antibodies Research(92)

Publications1.1k total

Supplementary Figure 1 from Adoptive Transfer of MART-1 T-Cell Receptor Transgenic Lymphocytes and Dendritic Cell Vaccination in Patients with Metastatic Melanoma
2023Open Access
Supplementary Data from IND-Enabling Studies for a Clinical Trial to Genetically Program a Persistent Cancer-Targeted Immune System
2023Open Access
Supplementary Figure 6 from Adoptive Transfer of MART-1 T-Cell Receptor Transgenic Lymphocytes and Dendritic Cell Vaccination in Patients with Metastatic Melanoma
2023Open Access
Supplementary Figure 2 from Adoptive Transfer of MART-1 T-Cell Receptor Transgenic Lymphocytes and Dendritic Cell Vaccination in Patients with Metastatic Melanoma
2023Open Access
Supplementary Figure 4 from Adoptive Transfer of MART-1 T-Cell Receptor Transgenic Lymphocytes and Dendritic Cell Vaccination in Patients with Metastatic Melanoma
2023Open Access
Data from Adoptive Transfer of MART-1 T-Cell Receptor Transgenic Lymphocytes and Dendritic Cell Vaccination in Patients with Metastatic Melanoma
2023Open Access
Supplementary Figure 7 from Adoptive Transfer of MART-1 T-Cell Receptor Transgenic Lymphocytes and Dendritic Cell Vaccination in Patients with Metastatic Melanoma
2023Open Access
Supplementary Figure 9 from Adoptive Transfer of MART-1 T-Cell Receptor Transgenic Lymphocytes and Dendritic Cell Vaccination in Patients with Metastatic Melanoma
2023Open Access
Supplementary Figure 2 from Adoptive Transfer of MART-1 T-Cell Receptor Transgenic Lymphocytes and Dendritic Cell Vaccination in Patients with Metastatic Melanoma
2023Open Access
Supplementary Methods, Figure Legends, Table 1 from Adoptive Transfer of MART-1 T-Cell Receptor Transgenic Lymphocytes and Dendritic Cell Vaccination in Patients with Metastatic Melanoma
2023Open Access
Supplementary Figure 6 from Adoptive Transfer of MART-1 T-Cell Receptor Transgenic Lymphocytes and Dendritic Cell Vaccination in Patients with Metastatic Melanoma
2023Open Access
Supplementary Methods, Figure Legends, Table 1 from Adoptive Transfer of MART-1 T-Cell Receptor Transgenic Lymphocytes and Dendritic Cell Vaccination in Patients with Metastatic Melanoma
2023Open Access
Supplementary Figure 8 from Adoptive Transfer of MART-1 T-Cell Receptor Transgenic Lymphocytes and Dendritic Cell Vaccination in Patients with Metastatic Melanoma
2023Open Access
Data from IND-Enabling Studies for a Clinical Trial to Genetically Program a Persistent Cancer-Targeted Immune System
2023Open Access
Supplementary Figure 3 from Adoptive Transfer of MART-1 T-Cell Receptor Transgenic Lymphocytes and Dendritic Cell Vaccination in Patients with Metastatic Melanoma
2023Open Access
Supplementary Figure 5 from Adoptive Transfer of MART-1 T-Cell Receptor Transgenic Lymphocytes and Dendritic Cell Vaccination in Patients with Metastatic Melanoma
2023Open Access
Data from Adoptive Transfer of MART-1 T-Cell Receptor Transgenic Lymphocytes and Dendritic Cell Vaccination in Patients with Metastatic Melanoma
2023Open Access
Supplementary Figure 8 from Adoptive Transfer of MART-1 T-Cell Receptor Transgenic Lymphocytes and Dendritic Cell Vaccination in Patients with Metastatic Melanoma
2023Open Access
Supplementary Figure 9 from Adoptive Transfer of MART-1 T-Cell Receptor Transgenic Lymphocytes and Dendritic Cell Vaccination in Patients with Metastatic Melanoma
2023Open Access
Data from IND-Enabling Studies for a Clinical Trial to Genetically Program a Persistent Cancer-Targeted Immune System
2023Open Access
← Previouspage 2 of 57Next →

Frequent Co-authors

Ryan M. O’Connell(6), Dinesh S. Rao(6), Konstantin D. Taganov(5), Mark Boldin(5), Cornelis Murre(4), Martin Scott(4), Ranjan Sen(3), Warren S. Pear(3), Sankar Ghosh(3), Aadel A. Chaudhuri(3), Amer A. Beg(2), Patrick A. Baeuerle(2), Patrick Page-McCaw(2), Garry P. Nolan(2), George Q. Daley(2), Michael J. Lenardo(2), Andrew B. Lassar(2), Harold Weintraub(2), Alexander Hoffmann(2), William C. Sha(2)